You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Adding topical pale sulfonated shale oil to compression therapy and moist wound care reduced venous leg ulcer size but had no effect on complete wound healing after 20 weeks

Article Text

Article menu
Download PDFPDF
Treatment
Adding topical pale sulfonated shale oil to compression therapy and moist wound care reduced venous leg ulcer size but had no effect on complete wound healing after 20 weeks

https://doi.org/10.1136/ebn.9.3.86

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Beckert S, Warnecke J, Zelenkova H, et al. Efficacy of topical pale sulfonated shale oil in the treatment of venous leg ulcers: a randomized, controlled, multicenter study. J Vasc Surg 2006;43:94–100.OpenUrlCrossRefPubMedWeb of Science

    Q Does topical application of pale sulfonated shale oil (PSSO) in addition to usual care with compression therapy and standard moist wound care improve healing of venous leg ulcers?

    METHODS

    Embedded ImageDesign:

    randomised controlled trial.

    Embedded ImageAllocation:

    {concealed}.*

    Embedded ImageBlinding:

    blinded {patients, healthcare providers, data collectors, and outcome assessors}.*

    Embedded ImageFollow up period:

    to the end of the 20 week treatment period.

    Embedded ImageSetting:

    13 outpatient wound clinics in Germany and Slovakia.

    Embedded ImagePatients:

    119 patients >18 years of age (mean age 69 y, 67% women) who had leg ulcers ⩾3 cm2 caused by chronic venous insufficiency. Exclusion criteria were severe cardiac, respiratory, gastrointestinal, liver, or renal disease; malignancy; signs of wound infection; and pregnancy or lactation.

    Embedded ImageIntervention:

    10% Leukichtan PSSO gel (Ichthyol-Gesellschaft, Germany) (n = 62) or placebo gel (n = 57). Both gels were applied daily …

    View Full Text

    Footnotes

    • ↵* Information provided by author.

    • ↵* Calculated from data in original article.

    • For correspondence: Dr S Beckert, Department of General and Transplant Surgery, Hoppe-Seyler-Str 3, Tübingen, Germany. stefan.beckert{at}med.uni-tuebingen.de

    • Source of funding: no external funding.